Business Description
Shelter Pharma Ltd
ISIN : INE013V01011
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.37 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 40.53 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.75 | |||||
Beneish M-Score | -0.3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.2 | |||||
3-Year FCF Growth Rate | -110.1 | |||||
3-Year Book Growth Rate | 71 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.36 | |||||
9-Day RSI | 46.54 | |||||
14-Day RSI | 49.52 | |||||
6-1 Month Momentum % | -12.71 | |||||
12-1 Month Momentum % | -26.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.91 | |||||
Quick Ratio | 9.09 | |||||
Cash Ratio | 2.31 | |||||
Days Inventory | 107.04 | |||||
Days Sales Outstanding | 75.6 | |||||
Days Payable | 5.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.63 | |||||
Dividend Payout Ratio | 0.06 | |||||
Forward Dividend Yield % | 0.63 | |||||
5-Year Yield-on-Cost % | 0.63 | |||||
Shareholder Yield % | 7.5 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.31 | |||||
Operating Margin % | 21.16 | |||||
Net Margin % | 14.82 | |||||
FCF Margin % | 20.15 | |||||
ROE % | 18.46 | |||||
ROA % | 17.24 | |||||
ROIC % | 21.45 | |||||
ROC (Joel Greenblatt) % | 38.45 | |||||
ROCE % | 24.99 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.08 | |||||
PE Ratio without NRI | 9.08 | |||||
PS Ratio | 1.36 | |||||
PB Ratio | 1.51 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Free-Cash-Flow | 6.67 | |||||
Price-to-Operating-Cash-Flow | 5.62 | |||||
EV-to-EBIT | 6.06 | |||||
EV-to-EBITDA | 5.92 | |||||
EV-to-Revenue | 1.25 | |||||
EV-to-FCF | 6.32 | |||||
Price-to-Graham-Number | 0.79 | |||||
Price-to-Net-Current-Asset-Value | 2.02 | |||||
Price-to-Net-Cash | 25.77 | |||||
Earnings Yield (Greenblatt) % | 16.5 | |||||
FCF Yield % | 14.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shelter Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 447.676 | ||
EPS (TTM) (₹) | 5.74 | ||
Beta | 0 | ||
Volatility % | 75.22 | ||
14-Day RSI | 49.52 | ||
14-Day ATR (₹) | 2.59811 | ||
20-Day SMA (₹) | 54.8135 | ||
12-1 Month Momentum % | -26.36 | ||
52-Week Range (₹) | 41.1 - 80.9 | ||
Shares Outstanding (Mil) | 11.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shelter Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shelter Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Shelter Pharma Ltd Frequently Asked Questions
What is Shelter Pharma Ltd(BOM:543963)'s stock price today?
When is next earnings date of Shelter Pharma Ltd(BOM:543963)?
Does Shelter Pharma Ltd(BOM:543963) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |